Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells

BioFactors

Volumn 31, Issue 3-4, 2007, Pages 155-164

  Zeng, Huawei ^a,b   Botnen, James H ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cancer; Colon; Gene array; Glutathione peroxidase; Selenium

Indexed keywords

ALPHA 2 MACROGLOBULIN; CXCL9 CHEMOKINE; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 27; HSPB2 PROTEIN; HUMAN HEDGEHOG INTERACTING PROTEIN; SELENITE; SELENIUM; SOMATOMEDIN BINDING PROTEIN 3; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CULTURE MEDIUM; DIETARY INTAKE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SELENIUM DEFICIENCY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 57349196417     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520310302     Document Type: Article

References (32)

1. O. Ali, P. Cohen and K.W. Lee, Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule, Horm Metab Res 35 (2003), 726-733.
2. B.C. Allan, G.M. Lacourciere and T.C. Stadtman, Responsiveness of selenoproteins to dietary selenium, Annu Rev Nutr 19 (1999), 1-16.
3. 2-macroglobulin abrogate binding of platelet-derived growth factor-BB and transforming growth factor-β1, J Biol Chem 281 (2006), 17061-17068.
4. M.V. Blagosklonny and A.B. Pardee, Exploiting cancer cell cycling for selective protection of normal cells, Cancer Res 61 (2001), 4301-4305.
5. 2-Macroglobulin, a multifunctional binding protein with targeting characteristics, FASEB J 6 (1992), 3345-3353.
6. A. J. Butt, S. M. Firth, M. A. King and R. C. Baxter, Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells, J Biol Chem 275 (2000), 39174-39181.
7. T.R. Chen, In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain, Exp Cell Res 104 (1977), 255-262.
8. L.C. Clark, G.F. Combs Jr, B.W. Turnbull, E.H. Slate, D.K. Chalker and J. Chow, et al., Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group, JAMA 276 (1996), 1957-1963.
9. G.F. Combs Jr, Current evidence and research needs to support a health claim for selenium and cancer prevention, J Nutr 135 (2005), 343-347.
10. C. Garrido, A. Fromentin, B. Bonnotte, N. Favre, M. Moutet, A.P. Arrigo, P. Mehlen and E. Solary, Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones, Cancer Res 58 (1998), 5495-5499.
11. A. Giulietti, L. Overbergh, D. Valckx, B. Decallonne, R. Bouillon and C. Mathieu, An overview of real-time quantitative PCR: applications to quantify cytokine gene expression, Method 25(2001), 386-401.
12. L.J. Guilbert and N.N. Iscove, Partial replacement of serum by selenite, transferring, albumin and lecithin in haemopoietic cell cultures, Nature (Lond) 263 (1976), 594-595.
13. O.Z. Hampel, M.W. Kattan, G. Yang, S.J. Haidacher, G.Y. Saleh, T.C. Thompson, T.M.Wheeler and M. Marcelli, Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study, J Urol 159 (1998), 2220-2225.
14. Institute of Medicine, Food and Nutrition Board Dietary Reference Intakesm Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academy Press, Washington, DC, 2000.
15. C. Ip, Lessons from basic research in selenium and cancer prevention, J Nutr 128 (1998), 1845-1854.
16. M.B. Irmak, G. Ince, M. Ozturk and R. Cetin-Atalay, Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: A selective survival mechanism? Cancer Res 63 (2003), 6707-6715.
17. M. Jacobs and C. Frost, Toxicological effects of sodium selenite in Sprague-Dawley rats, J Toxicol Environ Health 8 (1981), 575-585.
18. P.J. Jenkins, S. Khalaf , W. Ogunkolade, K. McCarthy, T. David, R.E. Hands, D. Davies and S.A. Bustin, Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis, Endocr Relat Cancer 12 (2005), 891-901.
19. i-independent signaling and actin responses in human intestinal myofibroblasts, J Immunol 175 (2005), 5403-5411.
20. J. Lu and C. Jiang, Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects, Nutr Cancer 40 (2001), 64-73.
21. J. Lu and C. Jiang, Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells, Antioxid Redox Signal 7 (2005), 1715-1727.
22. W.L. McKeehan, W.G. Hamilton and R.G. Ham, Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts, Proc Natl Acad Sci USA 73 (1976), 2023-2027.
23. C.L. Olsen, P.P. Hsu, J. Glienke, G.M. Rubanyi and A.R. Brooks, Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors, BMC Cancer 4 (2004), 43.
24. L.V. Papp, J. Lu, A. Holmgren and K.K. Khanna, From selenium to selenoproteins: synthesis, identity, and their role in human health, Antioxid Redox Signal 9 (2007), 775-806.
25. A. Parcellier, E. Schmitt, S. Gurbuxani, D. Seigneurin-Berny, A. Pance, A. Chantome, S. Plenchette, S. Khochbin, E. Solary and C. Garrido, HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation, Mol Cell Biol 23 (2003), 5790-802.
26. J. Pines, Cyclins, CDKs and cancer, Semin, Cancer Biol 6 (1995), 63-72.
27. J. Pines, The cell cycle kinases, Semin, Cancer Biol 5 (1994), 305-313.
28. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet and M. Egger, Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis, Lancet 363 (2004), 1346-1353.
29. Y, Saito, Y. Yoshida, T. Akazawa, K. Takahashi and E. Niki, Cell death caused by selenium deficiency and protective effect of antioxidants, J Biol Chem 278 (2003), 39428-39434.
30. P.D. Whanger, Selenium and its relationship to cancer: an update, Br J Nutr 91 (2004), 11-28.
31. H. Zeng and G.F. Combs Jr, Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion, J Nutr Biochem 19 (2008), 1-7.
32. H. Zeng, Selenite and selenomethionine promote HL-60 cell cycle progression, J Nutr 132 (2002), 674-679.